Context The effect of fish consumption or long-chain omega-3 polyunsaturated
fatty acid (PUFA) intake on risk of stroke remains uncertain.
Objective To examine the relation of fish consumption and long-chain omega-3 PUFA
intake and risk of stroke in men.
Design and Setting The Health Professional Follow-up Study, a US prospective cohort study
with 12 years of follow-up.
Participants A total of 43 671 men aged 40 to 75 years who completed a detailed
and validated semiquantitative food frequency questionnaire and who were free
of cardiovascular disease at baseline in 1986.
Main Outcome Measure Relative risk (RR) of stroke by subtype based on cumulative average
fish consumption or long-chain omega-3 PUFA intake, ascertained in 1986, 1990,
and 1994.
Results We documented 608 strokes during the 12-year follow-up period, including
377 ischemic, 106 hemorrhagic, and 125 unclassified strokes. Compared with
men who consumed fish less than once per month, the multivariate RR of ischemic
stroke was significantly lower among those who ate fish 1 to 3 times per month
(RR, 0.57; 95% confidence interval [CI], 0.35-0.95). However, a higher frequency
of fish intake was not associated with further risk reduction; the RR was
0.54 (95% CI, 0.31-0.94) for men who consumed fish 5 or more times per week.
This lack of linearity was confirmed by spline analyses. By dichotomized fish
intake, the multivariate RR for men who consumed fish at least once per month
compared with those who ate fish less than once per month was 0.56 (95% CI,
0.38-0.83) for ischemic stroke and 1.36 (95% CI, 0.48-3.82) for hemorrhagic
stroke. The inverse association between fish intake and risk of ischemic stroke
was not materially modified by use of aspirin. No significant associations
were found between fish or long-chain omega-3 PUFA intake and risk of hemorrhagic
stroke.
Conclusion Our findings suggest that eating fish once per month or more can reduce
the risk of ischemic stroke in men.
Ecological data prompted the hypothesis that fish consumption might
reduce the risk of ischemic stroke and increase the risk of hemorrhagic stroke.1-5 Long-chain
omega-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA), which are almost exclusively derived
from marine sources and inhibit platelet aggregation, might play an important
role in this effect.6-11
Epidemiological data on these associations are sparse because most studies
did not separate ischemic from hemorrhagic stroke, due to either small numbers
of hemorrhagic events or incomplete clinical information.12-15 In
the Nurses' Health Study, Iso and colleagues16 found
a significant inverse association between fish intake and risk of thrombotic
stroke but not hemorrhagic stroke. In a randomized trial among patients with
coronary heart disease, supplementation with omega-3 PUFAs at 1 g/d significantly
reduced the risk of acute myocardial infarction but was associated with a
nonsignificant increase in risk of stroke.17 However,
the amount of omega-3 PUFAs used in this trial exceeded those consumed typically
in diet, and fish oil supplementation may have different effects than fish
consumption.
Therefore, we prospectively examined the relation between fish intake
and risk of stroke in the Health Professional Follow-up Study (HPFS), a large
cohort of men who periodically completed dietary measurements during 12 years
of follow-up. We hypothesized that fish consumption or long-chain omega-3
PUFA intake reduces the risk of ischemic stroke but not hemorrhagic stroke.
The details of the HPFS have been described elsewhere.18 This
cohort was established in 1986, when 51 529 male health care professionals
aged 40 to 75 years responded to a mailed questionnaire that included a comprehensive
survey of diet, lifestyle characteristics, and medical history.19 Nondietary
variables were updated every other year and diet every 4 years. The follow-up
rates averaged 94% in each 2- or 4-year cycle. Men with certain diseases,
such as diabetes mellitus or transient ischemic attack, may change their diets
and are more likely to develop stroke. To eliminate the possible prognostic
bias, we excluded men at baseline with previously diagnosed stroke (n = 205),
myocardial infarction (n = 2221), coronary artery surgery (n = 967), angina
pectoris (n = 732), peripheral arterial disease (n = 517), diabetes mellitus
(n = 1181), transient ischemic attack (n = 276), or other cardiovascular disease
(n = 24). Furthermore, we excluded men whose baseline questionnaires had more
than 70 instances of missing data of 131 listed food items, those with daily
total energy intake of less than 800 or greater than 4200 calories (n = 1676),20 and those who did not provide information on fish
intake at baseline (n = 59). A total of 43 671 men were followed up from
1986 to 1998. The study design, data collection, and analysis plan were approved
by the Harvard School of Public Health Institutional Review Board.
Dietary information was collected through a semiquantitative food frequency
questionnaire19 in 1986, 1990, and 1994. Participants
were asked to indicate their average consumption of specified portions of
each selected food during the previous year, with 9 frequency options, ranging
from never or less than once per month to 6 or more times per day. Nutrient
intakes were calculated by multiplying the consumption frequency of each food
by the nutrient content of the specified portion according to composition
values from US Department of Agriculture (USDA) sources,21 manufacturers,
or published reports.19 Total nutrient intake
was the sum of the nutrients derived from different foods. With respect to
fish consumption, participants were asked about consumption of the following
amounts of 4 different items: canned tuna fish (3-4 oz [84-112 g]); dark-meat
fish such as mackerel, salmon, sardines, bluefish, and swordfish (3-5 oz [84-140
g]); other fish (3-5 oz [84-140 g]); and shrimp, lobster, or scallops as a
main dish (3.5 oz [98 g]). In this study, fish consumption was defined as
fish and other seafood intake. Therefore, total fish consumption was computed
as the sum of the frequencies of the above 4 items.22 Participants
were also asked about use of fish oil supplements in 1988, 1992, and 1996.
The estimation of long-chain omega-3 PUFA intake has been previously
described.16 Briefly, we obtained EPA and DHA
contents among each specific type of fish from the USDA nutrient database.21 Then, we weighted the values of long-chain omega-3
PUFAs for the most common types of fish according to US landing data (US Department
of Commerce).23 For example, in the 1994 questionnaire,
we weighted dark-meat fish as 58% salmon, 19% herring, 5% mackerel, 4% sardines,
1% bluefish, 1% swordfish, and 12% other dark-meat fish. The derived values
of long-chain omega-3 PUFA in 1 serving size were 0.41 g for canned tuna fish,
1.60 g for dark-meat fish, 0.56 g for other fish, and 0.26 g for shrimp, lobster,
or scallops as a main dish.
The reproducibility and validity of the questionnaire were evaluated
in a subset of 127 participants selected from the HPFS cohort.24 The
reproducibility was assessed by examining the correlations between 2 administrations
of the food frequency questionnaire 1 year apart. Correlations were 0.54 for
canned tuna, 0.63 for dark-meat fish, 0.48 for other fish, and 0.67 for shrimp,
lobster, or scallops as a main dish. In addition, comparing the food frequency
questionnaire to diet records, the correlations were 0.56 for canned tuna,
0.42 for dark-meat fish, 0.39 for other fish, and 0.23 for shrimp, lobster,
or scallops as a main dish.25 Moreover, long-chain
omega-3 PUFA intake from fish was compared with its concentration in participants'
adipose tissues. The Spearman correlation coefficient for intake of EPA and
percentage of EPA in adipose tissue was 0.49 (P<.001).26
End points were incident fatal and nonfatal strokes occurring between
the return of the baseline questionnaire and January 31, 1998. Stroke was
defined as sudden or rapid onset of a typical neurological defect of more
than 24-hour duration or leading to death that was attributable to a cerebrovascular
event. We wrote to participants who reported an incident stroke on a follow-up
questionnaire to request permission to review the medical records. The medical
records were reviewed by a physician blinded to risk factor status. Strokes
were classified as ischemic (embolism or thrombosis), hemorrhagic (subarachnoid
and intracerebral), or unknown according to the criteria of the National Survey
of Stroke.27 Information on fatal cases was
based on the report of next of kin, colleagues, postal authorities, or the
National Death Index. All cases of fatal stroke were confirmed by checking
medical records, autopsy reports, or death certificates.28
Each participant contributed person-time from the date of return of
the first questionnaire until the date of occurrence of stroke, death, or
the end of the follow-up period. Only the first event of interest was included
in the analysis. Incidence rates were calculated as number of stroke events
divided by person-time of follow-up in each category. Because a few men consumed
more than 5 servings of fish per week, we categorized participants into 5
groups: less than once per month, 1 to 3 times per month, once per week, 2
to 4 times per week, and 5 or more times per week. To account for changes
in diet during the follow-up and to best represent long-term intake, we related
the incidence of stroke between 1986 and 1990 to fish consumption reported
in 1986; the incidence of stroke between 1990 and 1994 to the average of fish
consumption reported in 1986 and 1990; and the incidence of stroke between
1994 and 1998 to the average consumption in 1986, 1990, and 1994. To determine
whether there were different effects of long-term and most recent fish consumption,
we also used baseline diet report and most recent diet report, respectively,
in relation to incidence of stroke. For example, when using the most recent
diet, we related the incidence of stroke between 1990 and 1994 to fish consumption
reported in 1990.
Relative risks (RRs) were computed by dividing the incidence rate of
stroke among men in a particular fish intake category by the incidence rate
among men in the lowest fish consumption group with adjustment for age (5-year
categories) and smoking status (never, past, or current smoker with 1-14,
15-24, or ≥25 cigarettes/d). The Mantel extension test was used to test
for linear trends.29 We also divided participants
into 5 categories according to their long-chain omega-3 PUFA intake (<0.05,
0.05-<0.2, 0.2-<0.4, 0.4-<0.6, or ≥0.6 g/d). The reference group
(<0.05 g/d) was set to have similar level of long-chain omega-3 PUFA intake
to the reference category of fish consumption. Relative risks with adjustment
for age and smoking were calculated in a similar way for fish consumption.
Since α-linolenic acid intake may compensate for the effect of low long-chain
omega-3 PUFA intake,30 we also examined the
modification of α-linolenic acid and its joint classification with long-chain
omega-3 PUFAs on stroke.
Multivariate RRs were estimated by using Cox proportional hazards models
with age (months) as the time variable. The RRs for total stroke and stroke
subtypes were examined separately. Some dietary and nondietary variables were
considered potential confounders and adjusted in the multivariate analyses.
Hypercholesterolemia was considered an intermediate variable so we adjusted
for it only at baseline. Since men were likely to change their diets after
development of diabetes mellitus, coronary heart disease, transient ischemic
attack, or peripheral arterial disease or diagnosis of hypercholesterolemia,
we stopped updating individual diet information after the occurrence of any
of these events. All nutrient intakes were energy adjusted, and total energy
intake was included in all regression models.20 The
median fish consumption or long-chain omega-3 PUFA intake in each category
was used as a continuous variable to test for linear trends. In addition,
propensity scores were used to further ensure that the comparison groups are
comparable with multivariate adjustment.31,32
The continuous measure of cumulative average fish consumption (servings
per week) was used to fit a restricted cubic spline model and to obtain a
smooth representation of the RR as a function of fish intake with adjustment
for the effects of potential confounders.33-35 We
used 4 knots to divide continuous fish intake into 5 intervals. To make the
graph more stable and meaningful, we deleted the observations with fish intake
higher than the 95th percentile when we fitted the spline model. All reported P values are 2-sided and P<.05
is considered statistically significant. Analyses were performed using SAS
software, version 8.0 (SAS Institute Inc, Cary, NC).
The age-adjusted baseline characteristics of the study population by
frequency of fish consumption are shown in Table 1. Men with high fish consumption were less likely to be current
smokers or overweight and more likely to have a history of hypertension and
hypercholesterolemia, to be physically active, and to use aspirin or multivitamin
supplements. To account for these differences, we adjusted for the corresponding
variables in multivariate analyses.
A total of 608 participants developed stroke during the 12-year follow-up.
Among these cases, 377 were confirmed as ischemic stroke, 106 were identified
as hemorrhagic stroke, and the remainder could not be classified from the
available medical documentation. The RRs of total stroke and stroke subtypes
according to cumulative average and most recent fish consumption or cumulative
average long-chain omega-3 PUFA intake are shown in Table 2. For cumulative average fish consumption, the risk of ischemic
stroke was lower among men in each category of fish consumption compared with
those who ate fish less than once per month. Even a small amount of fish consumption
(1-3 times per month) was associated with a significant reduction in risk
of ischemic stroke (RR, 0.57; 95% confidence interval [CI], 0.35-0.95), and
no further benefit was observed at higher levels of fish intake. The RR for
those who ate fish 5 or more times per week was 0.54 (95% CI, 0.31-0.94).
The test for trend was nonsignificant in both the age- and smoking-adjusted
model (P = .08) and the multivariate model (P = .28). Risk of hemorrhagic stroke was not significantly
associated with fish intake. These associations remained after controlling
for propensity scores. For instance, the RR for men in the highest fish intake
group was 0.51 (95% CI, 0.26-0.98) with adjustment for propensity scores,
which were derived from the same covariates in the multivariate analyses.
With most recent fish consumption, the RRs showed an overall pattern similar
to that of using cumulative average intake. However, they were somewhat attenuated
with respect to risk reduction of ischemic stroke. For example, the RR of
ischemic stroke for men who ate fish 5 or more times per week was 0.81 (95%
CI, 0.50-1.32) compared with men who ate fish less than once per month. Results
of analyses using baseline diet were similar to those obtained using cumulative
average diet (data not shown). The inverse association between fish consumption
and risk of ischemic stroke did not materially change after further adjusting
for use of antihypertensive medications.
For long-chain omega-3 PUFA intake, the RR of ischemic stroke was significantly
reduced for men in each category except the highest category compared with
those in the lowest one. The RR was attenuated to 0.73 (95% CI, 0.43-1.25)
among men in the highest category. No significant association was observed
between long-chain omega-3 PUFA intake and risk of hemorrhagic stroke (Table 2). Approximately 2.7% of participants
in this cohort used fish oil supplements. Among them, 19 men developed strokes
(12 ischemic and 7 of unknown type); the RR for fish oil users compared with
nonusers was 1.01 (95% CI, 0.55-1.86) for ischemic stroke. We also examined
the relation between cumulative average α-linolenic acid intake and
risk of stroke. There was no apparent or statistically significant overall
association between α-linolenic acid intake and risk of stroke (data
not shown).
By visual inspection, the restricted cubic spline curve (Figure 1) confirms the impression of a threshold of fish consumption
in relation to risk of ischemic stroke, in concordance with the categorical
analysis in Table 2. Therefore,
we dichotomized fish intake as less than once per month vs at least once per
month. The multivariate RRs for men who consumed fish at least once per month
compared with those who ate fish less than once per month were 0.72 (95% CI,
0.52-1.01) for total stroke, 0.56 (95% CI, 0.38-0.83) for ischemic stroke,
and 1.36 (95% CI, 0.48-3.82) for hemorrhagic stroke.
To determine whether and to what extent aspirin use or vitamin E intake
modifies the relation between fish consumption and risk of stroke, we stratified
the study population according to use of aspirin or vitamin E intake. The
number of hemorrhagic strokes was too small to be analyzed in the stratification
studies so only the multivariate RRs of ischemic strokes were investigated.
The overall inverse association between fish intake and risk of ischemic stroke
persisted in each subgroup and was not materially modified by use of aspirin
or vitamin E intake (Table 3).
Tests for interaction were not statistically significant.
To examine whether intake of α-linolenic acid modifies the association
between intake of long-chain omega-3 PUFAs and ischemic stroke, we created
3 equal categories of α-linolenic acid intake. We categorized the long-chain
omega-3 PUFA intake into 3 groups, making the lowest category of long-chain
omega-3 PUFA intake the same as the reference group for the omega-3 PUFA categorical
variable in Table 2, then equally
divided the remaining into 2 other categories. The inverse association between
long-chain omega-3 PUFA intake and risk of ischemic stroke was attenuated
among men in the highest tertile of α-linolenic acid intake (Table 4). None of the tests for interaction,
however, were significant.
In this large prospective study among male health care professionals,
we observed a 40% lower risk of ischemic stroke in men who consumed fish once
per month or more compared with those who ate fish less often. The cubic spline
curve leveled off at approximately 1 serving of fish per week, suggesting
that the beneficial effect of fish intake on risk of ischemic stroke might
be maximal at a relatively low level of consumption. No significant associations
were found between fish consumption or long-chain omega-3 PUFA intake and
risk of hemorrhagic stroke.
The prospective nature of the study design minimized the likelihood
of recall and selection biases, and the high follow-up rates largely reduced
the concern that the results have been affected by differential follow-up
rates. Also, our results were unlikely to be explained by confounding, since
the RR estimates did not materially change after simultaneous controlling
for potential confounding variables, including major lifestyle and dietary
risk factors. The similar results after adjustment for propensity scores further
supported our findings. However, the possibility of residual confounding by
unknown risk factors could not be excluded. In addition, our dietary assessments
were based on the previously validated semiquantitative food frequency questionnaires.
The range of exposure was wide, and we reduced error in dietary assessment
by using repeated measurements and cumulative average dietary intakes. To
estimate long-chain omega-3 PUFA intake, we assigned a value to each fish
item. Although these values were reasonably derived from the USDA database,
they should be considered approximations. Moreover, there was inevitable error
in estimating fish consumption, and we ignored the small amounts of long-chain
omega-3 PUFAs contributed by intake of poultry and other animal organs.36 However, the error in both fish and long-chain omega-3
PUFA intake would be mostly random and tend to dilute their associations with
stroke. Furthermore, our study focused on men without history of diabetes
and cardiovascular diseases. The generalizability may be limited by the unique
study base.
Inverse associations between fish intake and risk of stroke have been
previously reported. In the Zutphen study,12 men
who ate more than 20 g/d of fish had a 50% (RR, 0.49; 95% CI, 0.24-0.99) lower
risk of total stroke compared with those who consumed less than 20 g/d of
fish. In the National Health and Nutrition Examination Survey I Epidemiological
Follow-up Study,13 a modest and nonsignificant
risk reduction was observed in men who ate fish more than once per week compared
with those who never ate fish (RR, 0.85; 95% CI, 0.49-1.46). In the Physicians'
Health Study,14 compared with men whose fish
consumption was less than 1 meal per week, the adjusted RRs of stroke for
those who consumed 1 meal, 2 to 4 meals, and 5 or more meals per week were
0.9 (95% CI, 0.6-1.3), 0.8 (95% CI, 0.5-1.2), and 0.6 (95% CI, 0.3-1.6), respectively
(P for trend = .13). These studies did not separate
ischemic and hemorrhagic strokes12-14;
however, the results probably reflect the beneficial effects of fish intake
on risk of ischemic stroke, as it is more common than hemorrhagic stroke in
most populations. Iso et al16 found nonsignificant
inverse associations between fish intake and total or ischemic stroke in a
large cohort of women. The multivariate RR of ischemic stroke was 0.38 (95%
CI, 0.12-1.19; P for trend = .09) among women in
the highest fish intake category (≥5 times/wk) compared with women who
ate fish less than once per month. In addition, they found that the inverse
association was stronger and significant in analyses restricted to thrombotic
stroke; no excess risk of hemorrhagic stroke was found with high fish intake.
Furthermore, Albert et al37 found a threshold
effect on sudden cardiac death in the Physicians' Health Study. For men who
ate fish at least once per week, the multivariate RR of sudden death was 0.48
(95% CI, 0.24-0.96) compared with men who consumed fish less than once per
month.
Since both aspirin and long-chain omega-3 PUFAs decrease platelet aggregability
through the inhibition of thromboxane A2 synthesis, fish intake
may not provide any additional benefit among men using aspirin. However, we
did not find that aspirin use materially modified the apparent beneficial
effect of fish consumption on risk of ischemic stroke. Although the inverse
association was slightly strengthened among men with high vitamin E intake,
tests for interaction were nonsignificant between fish or long-chain omega-3
PUFA intake and use of vitamin E, a fat-soluble vitamin presumed to improve
the beneficial effect of fish on atherosclerosis and thrombosis by preventing
the auto-oxidation and peroxidation of omega-3 PUFAs.38-40 This
result is consistent with that of the GISSI prevention trial, in which the
effect of combined treatment with vitamin E and omega-3 PUFAs was similar
to that of omega-3 PUFAs alone with respect to risk of total stroke (mainly
ischemic stroke).17 In addition, the inverse
association between long-chain omega-3 PUFA intake and risk of ischemic stroke
was attenuated among men in the highest tertile of α-linolenic acid
intake. These results support the hypothesis that high α-linolenic acid
may compensate for the effect of low long-chain omega-3 PUFA intake because α-linolenic
acid can be converted to EPA.30 We did not
find an association between fish oil intake and risk of stroke, but the number
of men taking fish oil supplements was small.
A beneficial effect of fish consumption on ischemic stroke could be
related to the overall favorable effects of long-chain omega-3 PUFAs on lipid
profiles,41-44 platelet
activity,6,45,46 threshold
for arrhythmias,47 and endothelial function.48,49 In our study, even rather low fish
consumption was associated with a significantly lower risk of ischemic stroke.
The biological mechanism of the apparent beneficial effects of such a small
amount of fish intake and the lack of a dose response remain unclear. It is
of interest, however, that in a clinical trial, platelet aggregation was reduced
by supplementation with only 150 mg/d of EPA for 4 weeks.50 Conversely,
the antiplatelet effect and the observation of high incidence of hemorrhagic
stroke in native Alaskans, who consume a diet rich in long-chain omega-3 PUFA,
have raised concerns about possible adverse effects of high fish intake on
risk of hemorrhagic stroke. Although we did not find a significant association
between fish or long-chain omega-3 PUFA intake and risk of hemorrhagic stroke,
the 95% CIs of our RR estimates were wide due to a relatively small number
of cases. Therefore, further investigations are needed to address this question.
In summary, in this large cohort of men without history of cardiovascular
disease or diabetes, we observed a significantly lower risk of ischemic stroke
in men who consumed fish once per month or more compared with men who ate
fish less often. The possibility that high fish consumption increases risk
of hemorrhagic stroke could not be ruled out and needs further exploration.
1.Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland.
Am J Clin Nutr.1980;33:2657-2661.Google Scholar 2.Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland: incidence
of some chronic diseases 1950-1974.
Acta Med Scand.1980;208:401-406.Google Scholar 3.Yamori Y, Nara Y, Iritani N, Workman RJ, Inagami T. Comparison of serum phospholipid fatty acids among fishing and farming
Japanese populations and American inlanders.
J Nutr Sci Vitaminol (Tokyo).1985;31:417-422.Google Scholar 4.Bjerregaard P, Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease
in Greenland.
Int J Epidemiol.1988;17:514-519.Google Scholar 5.Zhang J, Sasaki S, Amano K, Kesteloot H. Fish consumption and mortality from all causes, ischemic heart disease,
and stroke: an ecological study.
Prev Med.1999;28:520-529.Google Scholar 6.Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?
Lancet.1978;2:117-119.Google Scholar 7.Hirai A, Hamazaki T, Terano T.
et al. Eicosapentaenoic acid and platelet function in Japanese.
Lancet.1980;2:1132-1133.Google Scholar 8.Knapp HR, Reilly IA, Alessandrini P, FitzGerald GA. In vivo indexes of platelet and vascular function during fish-oil administration
in patients with atherosclerosis.
N Engl J Med.1986;314:937-942.Google Scholar 9.Kristensen SD, Schmidt EB, Dyerberg J. Dietary supplementation with omega-3 polyunsaturated fatty acids and
human platelet function: a review with particular emphasis on implications
for cardiovascular disease.
J Intern Med Suppl.1989;225:141-150.Google Scholar 10.Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a
critical review.
J Lipid Res.1989;30:785-807.Google Scholar 11.Hui R, Robillard M, Falardeau P. Inhibition of vasopressin-induced formation of diradylglycerols in
vascular smooth muscle cells by incorporation of eicosapentaenoic acid in
membrane phospholipids.
J Hypertens.1992;10:1145-1153.Google Scholar 12.Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke: the Zutphen Study.
Stroke.1994;25:328-332.Google Scholar 13.Gillum RF, Mussolino ME, Madans JH. The relationship between fish consumption and stroke incidence: the
NHANES I Epidemiologic Follow-up Study (National Health and Nutrition Examination
Survey).
Arch Intern Med.1996;156:537-542.Google Scholar 14.Morris MC, Manson JE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the Physicians' Health
Study: a prospective study.
Am J Epidemiol.1995;142:166-175.Google Scholar 15.Orencia AJ, Daviglus ML, Dyer AR, Shekelle RB, Stamler J. Fish consumption and stroke in men: 30-year findings of the Chicago
Western Electric Study.
Stroke.1996;27:204-209.Google Scholar 16.Iso H, Rexrode KM, Stampfer MJ.
et al. Intake of fish and omega-3 fatty acids and risk of stroke in women.
JAMA.2001;285:304-312.Google Scholar 17.GISSI-Prevenzione Investigators. Dietary supplementation with omega-3 polyunsaturated fatty acids and
vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
Lancet.1999;354:447-455.Google Scholar 18.Rimm EB, Giovannucci EL, Willett WC.
et al. Prospective study of alcohol consumption and risk of coronary disease
in men.
Lancet.1991;338:464-468.Google Scholar 19.Willett WC, Sampson L, Stampfer MJ.
et al. Reproducibility and validity of a semiquantitative food frequency questionnaire.
Am J Epidemiol.1985;122:51-65.Google Scholar 20.Willett W. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998.
21.US Department of Agriculture. Composition of Foods—Raw, Processed, and Prepared. Washington, DC: US Dept of Agriculture; 1993.
22.Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine omega-3 fatty acids, fish intake, and the
risk of coronary disease among men.
N Engl J Med.1995;332:977-982.Google Scholar 23.Consumer and Food Economics Institute. Composition of Foods: Handbook 8 Series. Washington, DC: US Dept of Agriculture; 1976-1989.
24.Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative
food frequency questionnaire among male health professionals.
Am J Epidemiol.1992;135:1114-1126.Google Scholar 25.Feskanich D, Rimm EB, Giovannucci EL.
et al. Reproducibility and validity of food intake measurements from a semiquantitative
food frequency questionnaire.
J Am Diet Assoc.1993;93:790-796.Google Scholar 26.Hunter DJ, Rimm EB, Sacks FM.
et al. Comparison of measures of fatty acid intake by subcutaneous fat aspirate,
food frequency questionnaire, and diet records in a free-living population
of US men.
Am J Epidemiol.1992;135:418-427.Google Scholar 27.Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings.
Stroke.1981;12(2 pt 2 suppl 1):I13-I44.Google Scholar 28.Ascherio A, Rimm EB, Hernan MA.
et al. Relation of consumption of vitamin E, vitamin C, and carotenoids to
risk for stroke among men in the United States.
Ann Intern Med.1999;130:963-970.Google Scholar 29.Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel
procedure.
J Am Stat Assoc.1963;58:690-700.Google Scholar 30.McKeigue P. Diets for secondary prevention of coronary heart disease: can linolenic
acid substitute for oily fish?
Lancet.1994;343:1445.Google Scholar 31.Greenland S. Randomization, statistics, and causal inference.
Epidemiology.1990;1:421-429.Google Scholar 32.Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for
causal effects.
Biometrika.1983;70:41-55.Google Scholar 33.Durrleman S, Simon R. Flexible regression models with cubic splines.
Stat Med.1989;8:551-561.Google Scholar 34.Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical
analysis.
Epidemiology.1995;6:356-365.Google Scholar 35.Greenland S, Michels KB, Robins JM, Poole C, Willett WC. Presenting statistical uncertainty in trends and dose-response relations.
Am J Epidemiol.1999;149:1077-1086.Google Scholar 36.Raper NR, Cronin FJ, Exler J. Omega-3 fatty acid content of the US food supply.
J Am Coll Nutr.1992;11:304-308.Google Scholar 37.Albert CM, Hennekens CH, O'Donnell CJ.
et al. Fish consumption and risk of sudden cardiac death.
JAMA.1998;279:23-28.Google Scholar 38.Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase
its atherogenicity.
N Engl J Med.1989;320:915-924.Google Scholar 39.Meydani M, Natiello F, Goldin B.
et al. Effect of long-term fish oil supplementation on vitamin E status and
lipid peroxidation in women.
J Nutr.1991;121:484-491.Google Scholar 40.Steinberg D. Antioxidants in the prevention of human atherosclerosis: summary of
the proceedings of a National Heart, Lung, and Blood Institute Workshop: September
5-6, 1991, Bethesda, Maryland.
Circulation.1992;85:2337-2344.Google Scholar 41.Nestel PJ. Effects of omega-3 fatty acids on lipid metabolism.
Annu Rev Nutr.1990;10:149-167.Google Scholar 42.Harris WS. Omega-3 fatty acids and serum lipoproteins: human studies.
Am J Clin Nutr.1997;65(5 suppl):1645S-1654S.Google Scholar 43.Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary
fish oils in patients with hypertriglyceridemia.
N Engl J Med.1985;312:1210-1216.Google Scholar 44.Roche HM, Gibney MJ. Effect of long-chain omega-3 polyunsaturated fatty acids on fasting
and postprandial triacylglycerol metabolism.
Am J Clin Nutr.2000;71(1 suppl):232S-237S.Google Scholar 45.Leaf A, Weber PC. Cardiovascular effects of omega-3 fatty acids.
N Engl J Med.1988;318:549-557.Google Scholar 46.James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production.
Am J Clin Nutr.2000;71(1 suppl):343S-348S.Google Scholar 47.Kang JX, Leaf A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids.
Am J Clin Nutr.2000;71(1 suppl):202S-207S.Google Scholar 48.De Caterina R, Cybulsky MI, Clinton SK, Gimbrone Jr MA, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression
of proatherogenic and proinflammatory proteins in human endothelial cells.
Arterioscler Thromb.1994;14:1829-1836.Google Scholar 49.De Caterina R, Bernini W, Carluccio MA, Liao JK, Libby P. Structural requirements for inhibition of cytokine-induced endothelial
activation by unsaturated fatty acids.
J Lipid Res.1998;39:1062-1070.Google Scholar 50.Driss F, Vericel E, Lagarde M, Dechavanne M, Darcet P. Inhibition of platelet aggregation and thromboxane synthesis after
intake of small amount of icosapentaenoic acid.
Thromb Res.1984;36:389-396.Google Scholar